{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:47:13Z","timestamp":1791946033736,"version":"4.3.4"},"reference-count":125,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1033,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1111\/j.1365-2133.2012.11197.x","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T14:49:39Z","timestamp":1344005379000},"page":"5-19","source":"Crossref","is-referenced-by-count":380,"title":["Guidelines for the management of vitiligo: the European Dermatology Forum consensus"],"prefix":"10.1093","volume":"168","author":[{"given":"A.","family":"Taieb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Dell\u2019Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"De Pase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Eleftheriadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ezzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Gawkrodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Jouary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nieuweboer-Krobotova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Parsad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Passeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tanew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"van Geel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Whitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wolkerstorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Picardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the writing group of the Vitiligo European Task Force (VETF) in cooperation with the European Academy of Dermatology and Venereology (EADV) and the Union Europ\u00e9enne des M\u00e9decins Sp\u00e9cialistes (UEMS)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,11,2]]},"reference":[{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-540-69361-1_2","volume-title":"Vitiligo","author":"Taieb","year":"2010"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jaad.2003.12.044","article-title":"Characteristics of genetic epidemiology and genetic models for vitiligo","volume":"51","author":"Zhang","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force","volume":"20","author":"Ta\u00efeb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB4|cit4","volume-title":"Vitiligo","year":"2010"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMcp0804388","article-title":"Clinical practice: vitiligo","volume":"360","author":"Taieb","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB6|cit6","first-page":"CD003263","article-title":"Interventions for vitiligo","volume":"1","author":"Whitton","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/archderm.134.12.1532","article-title":"Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature","volume":"134","author":"Njoo","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archderm.135.9.1061","article-title":"Left-right comparison study of the combination of fluticasone propionate and UV-A vs either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo","volume":"135","author":"Westerhof","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archderm.1984.01650410073019","article-title":"Vitiligo treated with topical clobetasol propionate","volume":"120","author":"Kumari","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0738-081X(03)00045-2","article-title":"The treatment of hypopigmentation in children","volume":"21","author":"Schaffer","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB13|cit13","first-page":"88","article-title":"Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo","volume":"15","author":"Coskun","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/09546630903266761","article-title":"Mometasone cream versus pimecrolimus cream for the treatment of childhood vitiligo","volume":"21","author":"K\u00f6se","year":"2010","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1067\/mjd.2002.126250","article-title":"Topical tacrolimus for repigmentation of vitiligo","volume":"47","author":"Grimes","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB17|cit17","first-page":"490","article-title":"FK506 (tacrolimus) and endothelin combined treatment induces mobility of melanoblasts: new insights into follicular vitiligo repigmentation induced by topical tacrolimus on sun-exposed skin","volume":"164","author":"Lan","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1610-0387.2006.06124.x","article-title":"Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study","volume":"4","author":"Dawid","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1524-4725.2004.30058.x","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study","volume":"30","author":"Kawalek","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archderm.142.7.927","article-title":"A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo","volume":"142","author":"Mehrabi","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archderm.140.9.1065","article-title":"Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/archderm.142.2.252","article-title":"Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure","volume":"142","author":"Ostovari","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2230.2004.01632.x","article-title":"Topical tacrolimus for treatment of childhood vitiligo in Asians","volume":"29","author":"Kanwar","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-4632.2007.03282.x","article-title":"Two therapeutic challenges: periocular and genital vitiligo in children successfully treated with pimecrolimus cream","volume":"46","author":"Souza Leite","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2133.2011.10351.x","article-title":"A double-blind randomized placebo-controlled trial of topical tacrolimus 0.1% versus clobetasol propionate 0.05% in childhood vitiligo","volume":"165","author":"Ho","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1684\/ejd.2009.0779","article-title":"An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo","volume":"19","author":"Stinco","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1529-8019.2008.00198.x","article-title":"Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects","volume":"21","author":"Lotti","year":"2008","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1610-0387.2007.06455.x","article-title":"Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion","volume":"6","author":"Hartmann","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1346-8138.2010.01067.x","article-title":"Effectiveness of 0.1% topical tacrolimus in adult and children patients with vitiligo","volume":"38","author":"Udompataikul","year":"2011","journal-title":"J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1751-7125.2008.07558.x","article-title":"Tacrolimus-induced hyperpigmentation in a patch of vitiligo","volume":"7","author":"De","year":"2008","journal-title":"Skinmed"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/1011-1344(92)85080-E","article-title":"The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992","volume":"14","author":"Pathak","year":"1992","journal-title":"J Photochem Photobiol, B"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0001-7310(05)73153-7","article-title":"Consensus document on phototherapy: PUVA therapy and narrow-band UVB therapy","volume":"96","author":"Carrascosa","year":"2005","journal-title":"Actas Dermosifiliogr"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.2006.07584.x","article-title":"Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo","volume":"156","author":"Wu","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1468-3083.2006.02035.x","article-title":"Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study","volume":"21","author":"Bhatnagar","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1046\/j.1365-2133.2003.05482.x","article-title":"A randomized controlled trial of narrowband ultraviolet B vs. bath-psoralen plus ultraviolet A photochemotherapy for psoriasis","volume":"148","author":"Dawe","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2340\/00015555-0469","article-title":"Targeted broadband ultraviolet B phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study","volume":"88","author":"Asawanonda","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB37|cit37","first-page":"165","article-title":"Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5,8-trimethylpsoralen, and psoralen in vitiligo","volume":"66","author":"Pathak","year":"1984","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archderm.143.5.578","article-title":"Randomized double-blind trial of treatment of vitiligo: efficacy psoralen UVA therapy versus narrowband UVB therapy","volume":"143","author":"Yones","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0190-9622(97)70277-9","article-title":"PUVA-induced phototoxicity: incidence and causes","volume":"36","author":"Morrison","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0190-9622(88)70092-4","article-title":"Treatment of vitiligo with khellin and ultraviolet A","volume":"18","author":"Ortel","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000247517","article-title":"Photochemotherapy with topical khellin and sunlight in vitiligo","volume":"184","author":"Orecchia","year":"1992","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0781.2006.00222.x","article-title":"Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites","volume":"22","author":"Anbar","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2133.2007.07980.x","article-title":"The challenge of follow-up in narrowband ultraviolet B phototherapy","volume":"157","author":"Diffey","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","article-title":"Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy","volume":"42","author":"Njoo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","article-title":"Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A","volume":"133","author":"Westerhof","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1468-3083.2006.01413.x","article-title":"Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo","volume":"20","author":"Parsad","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1001\/archderm.138.12.1619","article-title":"Treatment of vitiligo with the 308\u2003nm xenon chloride excimer laser","volume":"138","author":"Baltas","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1468-3083.2003.00758.x","article-title":"Monochromatic excimer light (308\u2003nm): an immunohistochemical study of cutaneous T cells and apoptosis related molecules in psoriasis","volume":"17","author":"Bianchi","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1468-3083.2007.02151.x","article-title":"Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313\u2003nm) in the treatment of vitiligo - a multicentre controlled study","volume":"21","author":"Casacci","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1468-3083.2003.00818.x","article-title":"Monochromatic excimer light 308\u2003nm in the treatment of vitiligo: a pilot study","volume":"17","author":"Leone","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1600-0781.2011.00606.x","article-title":"Photo(chemo)therapy in vitiligo","volume":"27","author":"Pacifico","year":"2011","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB52|cit52","first-page":"1186","article-title":"Randomized controlled trial comparing the effectiveness of 308\u2003nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck","volume":"159","author":"Sassi","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-0781.2003.00005.x","article-title":"Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet B narrow band","volume":"19","author":"Castanedo-Cazares","year":"2003","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1468-3083.2006.02101.x","article-title":"Narrowband UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients","volume":"21","author":"Fai","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1468-3083.2011.04002.x","article-title":"Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right\/left double-blind comparative study","volume":"25","author":"Nordal","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09546630802155057","article-title":"The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial","volume":"20","author":"Esfandiarpour","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1468-3083.2003.00795.x","article-title":"Is the combination of calcipotriol and PUVA effective in vitiligo?","volume":"17","author":"Baysal","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2230.2005.02037.x","article-title":"Tacalcitol and narrow-band phototherapy in patients with vitiligo","volume":"31","author":"Leone","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0781.2006.00250.x","article-title":"Topical tacalcitol and 308\u2003nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo","volume":"22","author":"Tang","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1468-3083.2006.02016.x","article-title":"Combination of 308\u2003nm xenon chloride excimer laser and topical calcipotriol in vitiligo","volume":"21","author":"Goldinger","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaad.2010.12.007","article-title":"Combination treatment of non-segmental vitiligo with a 308-nm xenon chloride excimer laser and topical high-concentration tacalcitol: a prospective, single-blinded, paired, comparative study","volume":"65","author":"Oh","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1525-1470.1999.00083.x","article-title":"Calcipotriol in vitiligo: a preliminary study","volume":"16","author":"Parsad","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000246690","article-title":"Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study of 33 patients","volume":"190","author":"Schallreuter","year":"1995","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2133.2009.09252.x","article-title":"A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo","volume":"161","author":"Bakis-Petsoglou","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2230.2007.02514.x","article-title":"Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial","volume":"32","author":"Dell\u2019Anna","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1468-3083.2006.02132.x","article-title":"Treatment of vitiligo vulgaris with narrow band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo controlled study","volume":"21","author":"Middelkamp-Hup","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archderm.1992.01680170134031","article-title":"Repigmentation of leukotrichia by epidermal grafting and systemic psoralen plus UVA","volume":"128","author":"Hann","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1034\/j.1600-0749.2002.02034.x","article-title":"Approaches to repigmentation of vitiligo skin: new treatment with ultrasonic abrasion, seed-grafting and psoralen plus ultraviolet A therapy","volume":"15","author":"Tsukamoto","year":"2002","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0781.2008.00385.x","article-title":"Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study","volume":"24","author":"Anbar","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archderm.140.10.1203","article-title":"Double-blind placebo controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo","volume":"140","author":"Van Geel","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2133.2011.10564.x","article-title":"Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations","volume":"166","author":"Bayoumi","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2133.2011.10723.x","article-title":"Combination treatment by 10\u2003600\u2003nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study","volume":"166","author":"Shin","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1524-4725.2004.30003.x","article-title":"A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo","volume":"30","author":"Barman","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09546630600791442","article-title":"The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients","volume":"17","author":"Radmanesh","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB75|cit75","first-page":"18","article-title":"Evaluation of five different regimes for the treatment of vitiligo","volume":"55","author":"Pasricha","year":"1989","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-4362.1993.tb02754.x","article-title":"Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease","volume":"32","author":"Pasricha","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1067\/mjd.2001.113475","article-title":"Oral dexamethasone pulse treatment for vitiligo","volume":"44","author":"Radakovic-Fijan","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-4362.1999.00623.x","article-title":"The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients","volume":"38","author":"Kim","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0378-6323.42905","article-title":"An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad\/narrow band UVB phototherapy in progressive vitiligo","volume":"74","author":"Rath","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-4362.1979.tb01924.x","article-title":"Cyclophosphamide and vitiligo","volume":"18","author":"Gokhale","year":"1979","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archderm.1990.01670270071012","article-title":"Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis","volume":"126","author":"Gupta","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000102044","article-title":"Etanercept in the treatment of vitiligo","volume":"215","author":"Rigopoulos","year":"2007","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.jaad.2006.05.035","article-title":"Vitiligo after the resolution of psoriatic plaques during treatment with adalimumab","volume":"58","author":"Smith","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000081494","article-title":"Infliximab-induced vitiligo","volume":"210","author":"Ram\u00edrez-Hern\u00e1ndez","year":"2005","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0749.2006.00333.x","article-title":"A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo","volume":"19","author":"Dell\u2019Anna","year":"2006","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-540-69361-1_43","volume-title":"Vitiligo","author":"Picardo","year":"2010"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB87|cit87","first-page":"24","article-title":"The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA","volume":"12","author":"Akyol","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2230.2003.01207.x","article-title":"Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo","volume":"28","author":"Parsad","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB89|cit89","first-page":"215","article-title":"From basic research to bedside: efficacy of topical treatment with pseudo catalase PC-KUS in 71 children with vitiligo","volume":"188","author":"Schallreuter","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1468-3083.2008.02839.x","article-title":"A double-blind, randomized trial of 0.05% betamethasone vs topical catalase\/dismutase superoxide in vitiligo","volume":"22","author":"Sanclemente","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/jn\/137.9.2098","article-title":"Antioxidant supplementation increases the risk of skin cancers in women but not in men","volume":"137","author":"Hercberg","year":"2007","journal-title":"J Nutr"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/archderm.134.12.1543","article-title":"A systematic review of autologous transplantation methods in vitiligo","volume":"134","author":"Njoo","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB93|cit93","first-page":"144","volume-title":"Surgical Management of Vitiligo","author":"Gauthier","year":"2007"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1046\/j.1365-2133.2002.04837.x","article-title":"Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension","volume":"147","author":"Olsson","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1468-3083.2003.00718.x","article-title":"Surgical treatment of vitiligo. Why, when and how?","volume":"17","author":"Falabella","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/archderm.140.10.1273","article-title":"What are the needs for transplantation treatment in vitiligo, and how good is it?","volume":"104","author":"Olsson","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB97|cit97","first-page":"69","volume-title":"Surgical Management of Vitiligo","author":"Gupta","year":"2007"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB98|cit98","first-page":"37","article-title":"Standard guidelines of care for vitiligo surgery","volume":"74","author":"Parsad","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB99|cit99","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-4632.2010.04694.x","article-title":"A proposal for the treatment guideline in segmental vitiligo","author":"Lee","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1473-2165.2010.00479.x","article-title":"Camouflage for patients with vitiligo vulgaris improved their quality of life","volume":"9","author":"Tanioka","year":"2010","journal-title":"J Cosmet Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB101|cit101","volume-title":"\u2018La Voce dei Pazienti\u2019. Evidence Based Dermatology","author":"DePase","year":"2003"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000084751","article-title":"Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage","volume":"210","author":"Ongenae","year":"2005","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2230.1993.tb02234.x","article-title":"The hidden face of dermatology","volume":"18","author":"Savin","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clindermatol.2007.10.009","article-title":"Permanent makeup: indications and complications","volume":"26","author":"De Cuyper","year":"2008","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1067\/mjd.2000.103813","article-title":"Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser","volume":"42","author":"Njoo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1524-4725.2004.30313.x","article-title":"Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo","volume":"30","author":"Rao","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1600-0625.2006.00441.x","article-title":"Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin","volume":"15","author":"Kasraee","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1046\/j.1524-4725.2001.01101.x","article-title":"Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis","volume":"27","author":"Kim","year":"2001","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/9780470760116.ch26","volume-title":"Vitiligo","author":"Nordlund","year":"2000"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1600-0749.2006.00334.x","article-title":"Hypopigmenting agents: an updated review on biological, chemical and clinical aspects","volume":"19","author":"Solano","year":"2006","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1468-3083.2010.03876.x","article-title":"Depigmentation therapies for normal skin in vitiligo universalis","volume":"25","author":"Alghamdi","year":"2011","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1468-3083.2000.00038.x","article-title":"Depigmentation of the normally pigmented patches in universal vitiligo patients with cryotherapy","volume":"14","author":"Radmanesh","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2230.2009.03412.x","article-title":"Depigmentation therapy in vitiligo universalis with cryotherapy and 4-hydroxyanisole","volume":"35","author":"Di Nuzzo","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.03.022","article-title":"The burden of vitiligo: patient characteristics associated with quality of life","volume":"61","author":"Linthorst Homan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2133.2010.09828.x","article-title":"Appearance Research Collaboration. Vitiligo linked to stigmatization in British South Asian women: a qualitative study of the experiences of living with vitiligo","volume":"163","author":"Thompson","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB116|cit116","first-page":"433","volume-title":"Vitiligo","author":"Kostoupolou","year":"2009"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2133.2009.09077.x","article-title":"Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre","volume":"161","author":"Kostopolou","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2230.2009.03765.x","article-title":"Vitiligo is more than skin deep: a survey of members of the Vitiligo Society","volume":"35","author":"Talsania","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1034\/j.1600-0749.13.s8.9.x","article-title":"Intrinsic and extrinsic pathomechanisms in vitiligo","volume":"13","author":"Taieb","year":"2000","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1056\/NEJMc0805682","article-title":"An alpha-melanocyte-stimulating hormone analogue in erythropoietic protoporphyria","volume":"360","author":"Harms","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1600-0749.2007.00385.x","article-title":"Keratinocyte cultures from involved skin in vitiligo patients show an impaired in vitro behaviour","volume":"20","author":"Bondanza","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/sj.cgt.7701000","article-title":"Protection of normal human reconstructed epidermis from UV by catalase overexpression","volume":"14","author":"Rezvani","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2008.08923.x","article-title":"Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo","volume":"160","author":"Kapoor","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/sj.jid.5700372","article-title":"Low-energy helium-neon laser induces locomotion of the immature melanoblasts and promotes melanogenesis of the more differentiated melanoblasts: recapitulation of vitiligo repigmentation in vitro","volume":"126","author":"Lan","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2012.11197.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2012.11197.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2012.11197.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T01:07:02Z","timestamp":1714266422000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/168\/1\/5\/6614430"}},"subtitle":["EDF vitiligo guidelines"],"short-title":[],"issued":{"date-parts":[[2012,11,2]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11197.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.724196910.793501769","asserted-by":"object"}]},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11,2]]}}}